Leukemia News and Research

RSS
Leukemia (Leukaemia) is a cancer of the blood cells. It is the most common type of blood cancer and affects 10 times as many adults as children. Most people diagnosed with leukemia are over 50 years old. No one knows why some people develop leukemia and others do not. However, scientists have identified some risk factors for the disease. Most people who have known risk factors do not get leukemia, while many who do get the disease have none of these risk factors. During the early stages of leukemia, there may be no symptoms. Many of the symptoms of leukemia don't become apparent until a large number of normal blood cells are crowded out by leukemia cells.
New approach helps immune cells find and attack solid tumors

New approach helps immune cells find and attack solid tumors

Study reveals genetic impact of Agent Orange on bone marrow cancers

Study reveals genetic impact of Agent Orange on bone marrow cancers

Cancer cells rely on glutathione as fuel for growth

Cancer cells rely on glutathione as fuel for growth

New CAR-T cell therapy shows promise for treating osteosarcoma

New CAR-T cell therapy shows promise for treating osteosarcoma

New method creates longer lasting CAR T cells for cancer therapy

New method creates longer lasting CAR T cells for cancer therapy

Fertility treatments linked to small increases in some cancers

Fertility treatments linked to small increases in some cancers

Simplified nanoparticles "educate"  the immune system to find and destroy disease-causing cells

Simplified nanoparticles "educate" the immune system to find and destroy disease-causing cells

Biomimetic platform enhances CAR T therapy for relapsed and refractory leukemia

Biomimetic platform enhances CAR T therapy for relapsed and refractory leukemia

Ketone body can strengthen the fitness and antitumor activity of CAR T cells

Ketone body can strengthen the fitness and antitumor activity of CAR T cells

Reducing miRNA levels helps rescue vascular defects in Rett syndrome

Reducing miRNA levels helps rescue vascular defects in Rett syndrome

Next-generation CAR T therapy offers hope but faces clinical challenges

Next-generation CAR T therapy offers hope but faces clinical challenges

Ochsner MD Anderson Cancer Center delivers Louisiana’s first TIL therapy for melanoma

Ochsner MD Anderson Cancer Center delivers Louisiana’s first TIL therapy for melanoma

Engineered Listeria boosts innate immunity against cancer

Engineered Listeria boosts innate immunity against cancer

ASH releases new guidelines for treating leukemia in adolescents and young adults

ASH releases new guidelines for treating leukemia in adolescents and young adults

Case report examines potential cancer risks after mRNA vaccination

Case report examines potential cancer risks after mRNA vaccination

Trial highlights promising frontline therapy for blastic plasmacytoid dendritic cell neoplasm

Trial highlights promising frontline therapy for blastic plasmacytoid dendritic cell neoplasm

FDA label update expands CAR T access for primary CNS lymphoma

FDA label update expands CAR T access for primary CNS lymphoma

Novel RNA molecule may influence patient survival in certain blood cancers

Novel RNA molecule may influence patient survival in certain blood cancers

Study explores how shared cells influence health across generations

Study explores how shared cells influence health across generations

New study exposes a targetable vulnerability in acute myeloid leukemia

New study exposes a targetable vulnerability in acute myeloid leukemia

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.